NEW YORK – Natera reported after the close of the market on Wednesday a 19 percent increase in third quarter revenues, driven by increased sales of its Panorama noninvasive prenatal and Horizon carrier screening tests.
"Q3 was in many ways a transformational quarter for Natera," said CEO Steve Chapman in a statement. "We continued to see strong momentum in volume growth and improved average selling price per test."